Literature DB >> 3907901

Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells.

S Kawana, W D Geoghegan, R E Jordon.   

Abstract

We have previously demonstrated that pemphigus antibodies will fix complement to organ and tissue cultured epidermal cells in vitro. In the present study, we sought to determine the role complement plays in the detachment of cultured murine epidermal cells by pemphigus antibody. Forty-eight hour cultivated epidermal monolayers from neonatal BALB/c mice were treated with purified IgG fractions of pemphigus sera in the presence or absence of complement. In the absence of complement, pemphigus IgG produced slight cell detachment when compared to an identical amount of normal IgG. When cells were maintained in media with pemphigus IgG plus complement for 48 h, the cell detachment was significantly higher than that obtained with pemphigus IgG alone, or with normal IgG plus complement. Heat inactivation or Clq depletion of the complement source resulted in complete inhibition of cell detachment. When pemphigus F(ab')2 plus complement was used instead of whole pemphigus IgG plus complement, the cell detachment rate was again lowered significantly. Both pemphigus IgG and the complement source were depleted of plasminogen by passage over a lysine-Sepharose 4B column, and tested for their effects on cell detachment depleted of plasminogen. Depletion of plasminogen failed to inhibit cell detachment induced by pemphigus IgG and complement. These results suggest that complement activated by pemphigus antibody binding to the epidermal cell surface induces epidermal cell detachment and would argue against the plasminogen-plasmin system as the sole cause of cell detachment in pemphigus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907901      PMCID: PMC1577285     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase.

Authors:  R M Farb; R Dykes; G S Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

2.  Pemphigoid and pemphigus antigens in cultured epidermal cells.

Authors:  L A Diaz; C L Marcelo
Journal:  Br J Dermatol       Date:  1978-06       Impact factor: 9.302

3.  Capability of complement fixation of pemphigus antibodies in vitro.

Authors:  T Nishikawa; S Kurihara; T Harada; M Sugawara; H Hatano
Journal:  Arch Dermatol Res       Date:  1977-10-27       Impact factor: 3.017

4.  An organ culture model for the study of pemphigus acantholysis.

Authors:  B Michel; C S Ko
Journal:  Br J Dermatol       Date:  1977-03       Impact factor: 9.302

5.  Studies of the antibodies in pemphigoid and pemphigus.

Authors:  W M Sams; P H Schur
Journal:  J Lab Clin Med       Date:  1973-08

6.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

7.  Complement activation in pemphigus vulgaris blister fluid.

Authors:  R E Jordan; N K Day; J R Luckasen; R A Good
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

8.  Classical and alternate pathway activation of complement in pemphigus vulgaris lesions.

Authors:  R E Jordon; A L Schroeter; R S Rogers; H O Perry
Journal:  J Invest Dermatol       Date:  1974-09       Impact factor: 8.551

9.  Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma.

Authors:  E A Bauer; J M Gordon; M E Reddick; A Z Eisen
Journal:  J Invest Dermatol       Date:  1977-10       Impact factor: 8.551

10.  Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.

Authors:  R E Jordon; F C McDuffie
Journal:  Proc Soc Exp Biol Med       Date:  1976-03
View more
  9 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Characterization of keratocalmin, a calmodulin-binding protein from human epidermis.

Authors:  J A Fairley; G A Scott; K D Jensen; L A Goldsmith; L A Diaz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Complement fixation by Brazilian Pemphigus foliaceus autoantibodies.

Authors:  S Kawana; L A Diaz; E A Rivitti; W D Geoghegan; R E Jordon
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.

Authors:  P Xia; R E Jordon; W D Geoghegan
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.

Authors:  R W Eyre; J R Stanley
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Membrane attack complex of complement in Henoch-Schönlein purpura skin and nephritis.

Authors:  S Kawana; G H Shen; Y Kobayashi; S Nishiyama
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 7.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

8.  Subclass distribution of human IgG autoantibodies in pemphigus.

Authors:  C C Jones; R G Hamilton; R E Jordon
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

9.  Sparking Fire Under the Skin? Answers From the Association of Complement Genes With Pemphigus Foliaceus.

Authors:  Valéria Bumiller-Bini; Gabriel Adelman Cipolla; Rodrigo Coutinho de Almeida; Maria Luiza Petzl-Erler; Danillo Gardenal Augusto; Angelica Beate Winter Boldt
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.